Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Current Leases (2022 - 2025)

Intelligent Bio Solutions has reported Current Leases over the past 3 years, most recently at $274834.0 for Q2 2024.

  • For Q2 2024, Current Leases rose 23.0% year-over-year to $274834.0; the TTM value through Jun 2024 reached $274834.0, up 23.0%, while the annual FY2024 figure was $274834.0, 23.0% up from the prior year.
  • Current Leases for Q2 2024 was $274834.0 at Intelligent Bio Solutions, up from $260377.0 in the prior quarter.
  • Over five years, Current Leases peaked at $274834.0 in Q2 2024 and troughed at $160826.0 in Q4 2022.
  • A 3-year average of $224552.0 and a median of $227414.0 in 2023 define the central range for Current Leases.
  • Biggest five-year swings in Current Leases: soared 55.91% in 2023 and later rose 23.0% in 2024.
  • Year by year, Current Leases stood at $160826.0 in 2022, then skyrocketed by 55.91% to $250751.0 in 2023, then rose by 9.6% to $274834.0 in 2024.
  • Business Quant data shows Current Leases for INBS at $274834.0 in Q2 2024, $260377.0 in Q1 2024, and $250751.0 in Q4 2023.